PCH
Polar Capital Holdings’s Avidity Biosciences RNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $50.3M | Sell |
1,770,387
-18,481
| -1% | -$525K | 0.26% | 90 |
|
|
2025
Q1 | $52.8M | Buy |
1,788,868
+516,977
| +41% | +$15.3M | 0.32% | 89 |
|
|
2024
Q4 | $37M | Sell |
1,271,891
-270,235
| -18% | -$7.86M | 0.21% | 117 |
|
|
2024
Q3 | $70.8M | Buy |
1,542,126
+428,025
| +38% | +$19.7M | 0.34% | 65 |
|
|
2024
Q2 | $45.5M | Buy |
+1,114,101
| New | +$45.5M | 0.27% | 87 |
|